Search
Displaying 391–400 of 689 for “retinitis clinical trial”
-
Eye on the Cure Podcast | Episode 35: Kenji Fujita, MD
Eye on the CureNovember 18, 2022. Ben Shaberman talks with Kenji Fujita, MD.
-
Advocating for the Foundation Through Professional Outreach
Beacon StoriesAs a longtime supporter and advocate for the Foundation Fighting Blindness, Lora has recently begun working with the Professional Outreach team. Lora’s work helps eye care professionals in the Philadelphia region provide vital resources for their patients with inherited retinal diseases.
-
FDA Approves Genentech’s Susvimo for Treating Wet AMD
Research NewsThe approach significantly reduces the need for regular ocular injections.
-
Foundation Fighting Blindness to Host Fall National Virtual VisionWalk
Foundation NewsThe Virtual VisionWalk on October 24th will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Most people are able to make a far more significant gift by including the Foundation in their will or trust or making a gift by beneficiary designation. Often called “legacy gifts”, these types of deferred gifts allow you to continue to be part of ending blindness for many decades to come.
-
The Foundation Receives a $100,000 Research Grant from Sofia Sees Hope
Research NewsSofia Sees Hope, a nonprofit dedicated to finding treatments and cures for people with Leber congenital amaurosis (LCA) and other inherited retinal diseases (IRDs), has made a $100,000 donation to the Foundation Fighting Blindness to support therapy development and genetic testing.
-
Foundation Invests $2.5 Million in Search for Elusive Retinal Disease Genes and Mutations
Research NewsSince 1989 genetic researchers, many funded by the Foundation, have identified approximately 270 genes linked to IRDs. In most cases, defects in a single gene can cause a retinal disease and vision loss.
-
ARVO 2018: Port Delivery System Designed to Reduce Burden of Lucentis Injections for Wet AMD
Research NewsDr. Christopher Brittain, Genentech medical director, discusses his company’s port delivery system, a tiny capsule implanted into the eye, for delivery of Lucentis® over a period of a few months.
-
Research News
The partnership will help companies and researchers quickly obtain and implement high-quality vectors for their retinal gene-therapy development efforts.
-
Embrace Your Exceptions: A Mantra for Understanding Retinal-Disease Inheritance
Research NewsThe complex and elusive nature of these conditions can also extend to the way they are passed down in families, making diagnosis and prognosis quite challenging.
.png)
.png)
